Editorials

• Lights and (Some) Shadows in the Management of Acute Coronary Syndrome in Spain: the DIOCLES Study

  Xavier Garcia-Moll

  Rev Esp Cardiol. 2015;68:85-6

• Mendelian Randomization: Present and Future of Epidemiological Studies in Cardiology

  Ignacio Iturrieta-Zuazo, Stefan Walter

  Rev Esp Cardiol. 2015;68:87-91

• Comments on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization

  A. Cequier

  Rev Esp Cardiol. 2015;68:92-7

• Endless Validation of Diagnostic Imaging Modalities to Assess Acute Coronary Syndrome: Has the Time Finally Come for Computed Tomography Angiography?

  Jorge Romero, Mario J. Garcia

  Rev Esp Cardiol. 2015;68:1-3

• Comments on the 2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism

  SEC Working Group for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism, Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism, SEC Clinical Practice Guidelines Committee

  Rev Esp Cardiol. 2015;68:10-6

• Comments on the 2014 ESC Guidelines on the Diagnosis and Management of Hypertrophic Cardiomyopathy. A Critical View From the Perspective of Spanish Cardiology

  SEC Working Group for the 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy, Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Hypertrophic Cardiomyopathy, SEC Clinical Practice Guidelines Committee

  Rev Esp Cardiol. 2015;68:4-9

• Restratification at Time of Implantable Cardioverter Defibrillator Replacement

  Iwona Cygankiewicz, Pawel Ptaszynski

  Rev Esp Cardiol. 2014;67:971-3

• Paclitaxel-eluting Stents in ST-segment Elevation Myocardial Infarction

  Ernest Spitzer, Stephan Windecker

  Rev Esp Cardiol. 2014;67:974-9

• Comments on the 2014 ESC/ESA Guidelines on Noncardiac Surgery: Cardiovascular Assessment and Management1

  J.A. San Román

  Rev Esp Cardiol. 2014;67:980-5

• Shall CRT-D Be Downgraded to CRT-P in Super-responders of Cardiac Resynchronization Therapy?

  Fang Fang, Cheuk-Man Yu

  Rev Esp Cardiol. 2014;67:875-7

• Resistant Hypertension and Renal Denervation. Considerations on the Results of the Symplicity HTN-3 Trial

  Luis M. Ruilope, Fernando Arribas

  Rev Esp Cardiol. 2014;67:881-2

• Next-generation Transcatheter Aortic Valves. An Opportunity to Expand Therapeutic Indications?

  Manuel Pan, José Suárez de Lezo

  Rev Esp Cardiol. 2014;67:878-80

• Myocardial Injury After Noncardiac Surgery

  Pilar Paniagua Iglesias, Susana Díaz Ruano, Jesús Álvarez-García, on behalf of the VISION study collaborating researchers in Spain

  Rev Esp Cardiol. 2014;67:794-6

• Do We Know How to Treat Bifurcation Coronary Lesions?

  Fernando Alfonso, Manuel Pan

  Rev Esp Cardiol. 2014;67:790-3

• Coronary Bifurcations: Still the Touchstone of Drug-eluting Stents and Bioresorbable Vascular Scaffolds?

  Clemens von Birgelen, K. Gert van Houwelingen, Ming Kai Lam

  Rev Esp Cardiol. 2014;67:787-9

• Polypill: Chimera or Reality?

  Ginés Sanz, José M. Castellano, Valentín Fuster

  Rev Esp Cardiol. 2014;67:689-92

• The Integral Nature of Cardiac Magnetic Resonance Imaging in the Work-up for Ischemic Heart Disease

  Guillem Pons Lladó

  Rev Esp Cardiol. 2014;67:683-4

• Screening for Familial Hypercholesterolemia: a Model for Preventive Medicine

  Pedro Mata, Rodrigo Alonso, Francisco Pérez-Jiménez

  Rev Esp Cardiol. 2014;67:685-8

• Rethinking Percutaneous Paravalvular Leak Closure: Where Do We Go From Here?

  Chad Kliger, Carlos E. Ruiz

  Rev Esp Cardiol. 2014;67:593-6

• The Transitive Property Across Randomized Controlled Trials: If B Is Better Than A, and C Is Better Than B, Will C Be Better Than A?

  Ferrán Catalá-López, Brian Hutton, David Moher

  Rev Esp Cardiol. 2014;67:597-602